Create Your Own Business Intelligence Website
Input the stock code or the company name     Search  

<01672.HK> - ASCLETIS PHARMA INC.

 
 Basic Datum
Company name Lot P/E P/B EPS DPS
ASCLETIS-B 1000 -9.89 0.585 -0.1477 0.0
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2022-12-21 歌禮製藥(1672)周一晚宣布旗下口服新冠藥物收到美國專利與商標局(USPTO)的授權公告通知書,公告日期為2023年1月3日。歌禮的口服病毒聚合酶抑制劑ASC10和衍生物可用於治療新冠病毒、猴痘病毒及人呼吸道合胞病毒(RSV)。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 05-02 09:30 17797.7  34.7  0.2%
ASCLETIS-B 05-03 16:08 1.42  1.42  ∞%
≫More
 
 

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved